Negative Pressure Wound Therapy Market Size, Reort 2030F

Report Description

Forecast Period	2026-2030
Market Size (2024)	USD 2640.52 Million
Market Size (2030)	USD 3791.99 Million
CAGR (2025-2030)	6.09%
Fastest Growing Segment	Hospitals
Largest Market	North America

Market Overview

Global Negative Pressure Wound Therapy Market was valued at USD 2640.52 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.09% through 2030F. The Global Negative Pressure Wound Therapy (NPWT) Market encompasses medical technologies designed to treat various wounds and ulcers by applying negative pressure, thereby promoting healing and managing exudate. This market has seen significant growth, driven by the increasing prevalence of chronic conditions such as diabetes and obesity, which often lead to complex wounds like diabetic foot ulcers and pressure ulcers. Technological advancements have further propelled market expansion, with innovations such as portable and disposable NPWT devices enhancing patient convenience and broadening the scope of treatment settings. According to the World Health Organization (WHO), as of 2014, approximately 422 million adults were living with diabetes globally, a significant increase from 108 million in 1980. This rise in diabetes prevalence has been associated with an increased risk of various complications, including infections, ulcerations (such as leg or foot ulcers), and acute wounds like surgical and traumatic wounds. Effective management of diabetes is crucial to reduce the occurrence and complexity of these wound-related complications.

The market is segmented into conventional NPWT devices, single-use NPWT devices, and accessories, with conventional devices currently holding the largest share due to their widespread adoption in hospitals and clinics. However, single-use devices are gaining traction, particularly in home care settings, due to their ease of use and cost-effectiveness. Geographically, North America dominates the market, attributed to advanced healthcare infrastructure and high awareness levels, while the Asia-Pacific region is anticipated to experience the fastest growth, driven by improving healthcare facilities and a rising patient population. Overall, the NPWT market is poised for continued expansion, fueled by ongoing research, product innovations, and the escalating need for effective wound management solutions.

Key Market Drivers

Aging Population

The global healthcare landscape is undergoing a transformation, driven in part by the aging population. For instance, according to the World Health Organization (WHO), the global population is experiencing a significant demographic shift. By 2030, one in six individuals worldwide will be aged 60 years or older, increasing the number of people in this age group from 1 billion in 2020 to 1.4 billion. Looking further ahead, projections indicate that by 2050, the global population of those aged 60 and above will double to reach 2.1 billion. As people worldwide are living longer, they are also experiencing an increased prevalence of chronic health conditions, leading to a greater demand for advanced medical treatments. One such treatment that has seen significant growth is Negative Pressure Wound Therapy (NPWT). The world's population is aging at an unprecedented rate. According to the United Nations, by 2050, the global population aged 60 and above is expected to reach 2.1 billion, nearly double what it was in 2017. This demographic shift is significant because aging is often accompanied by health issues that can lead to chronic wounds, including diabetes, circulatory problems, and pressure ulcers. Aging is a natural process, but it is also associated with an increased likelihood of chronic health conditions. Chronic diseases such as diabetes, peripheral vascular disease, and obesity become more prevalent with age. For instance, the World Obesity Federation projects that by 2030, approximately one billion individuals globally—comprising one in five women and one in seven men—will be living with obesity. Obesity is associated with an increased risk of pressure ulcers due to factors such as reduced mobility, increased pressure on load-bearing tissues, and skin shear during movement. Consequently, the rising prevalence of obesity is expected to drive demand for pressure ulcer prevention and management products, contributing to market growth.

These conditions can lead to slow-healing or non-healing wounds, which are often challenging to manage. NPWT has emerged as a crucial tool in addressing these complex wounds effectively. Aging patients often present with complex wounds that require specialized care. NPWT provides a non-invasive and advanced wound management solution that can significantly improve the healing process. Its ability to remove excess fluid, reduce infection risk, and promote tissue granulation makes it an attractive option for healthcare professionals dealing with elderly patients. The cost of treating chronic wounds in aging populations can be substantial. Extended hospital stays, frequent outpatient visits, and the risk of complications all contribute to healthcare expenditures. NPWT can help reduce the economic burden by facilitating faster wound healing, thus lowering hospitalization durations and the overall cost of care. The elderly population often faces diminished quality of life due to chronic wounds that limit mobility and independence. NPWT can enhance the quality of life for these patients by expediting wound closure and reducing pain. As a result, patients can regain their mobility and independence more quickly.

Emerging Markets

The Global Negative Pressure Wound Therapy (NPWT) market has been witnessing remarkable growth, driven by several factors, including advancements in medical technology and increased awareness about the benefits of NPWT. One noteworthy contributor to this growth is the burgeoning presence of emerging markets. These regions, characterized by rapid economic development and an expanding healthcare infrastructure, hold immense potential to propel the NPWT market to new heights. Emerging markets, often found in developing countries, are characterized by dynamic economic growth, increasing healthcare expenditures, and a growing middle-class population. These markets are witnessing a transformation in healthcare delivery, with improved access to advanced medical treatments and technologies. As a result, they offer a promising landscape for healthcare-related industries, including the NPWT market. In April 2023, Convatec Group PLC acquired 30 Technology Limited's anti-infective nitric oxide technology platform, including new product assets and research and development. This strategic move aims to enhance Convatec's advanced wound care portfolio and explore applications across other business categories.

Emerging markets are experiencing a surge in chronic diseases, such as diabetes, obesity, and cardiovascular disorders. These conditions are associated with a higher risk of non-healing wounds, making NPWT a vital tool in wound management and accelerating healing. As the prevalence of these diseases increases, so does the demand for NPWT. Emerging markets are witnessing a rise in surgical procedures, driven by factors such as increased healthcare spending, the adoption of modern medical practices, and a growing aging population. Surgical wounds often benefit from NPWT, leading to a higher demand for this technology. Emerging markets are investing heavily in expanding their healthcare infrastructure, including the establishment of modern hospitals and clinics. With a growing number of healthcare facilities, there is a greater opportunity for the adoption of NPWT technology. As healthcare literacy improves in emerging markets, both healthcare professionals and patients become more aware of advanced wound care solutions like NPWT. This increased awareness drives demand and adoption rates. NPWT, although initially considered expensive, can be a cost-effective solution in the long run, especially in emerging markets where the cost of hospital stays, and post-operative care can be high. This cost-effectiveness is encouraging healthcare providers and policymakers to embrace NPWT.

Rise in Chronic Diseases

The Global Negative Pressure Wound Therapy (NPWT) market is experiencing remarkable growth, and one of the key drivers behind this expansion is the alarming increase in chronic diseases worldwide. These conditions, which include diabetes, obesity, cardiovascular diseases, and more, often lead to chronic wounds that require sophisticated wound care solutions like NPWT. Chronic diseases have reached epidemic proportions globally, posing a significant public health challenge. The World Health Organization (WHO) reports that chronic diseases account for approximately 71% of all global deaths, making them the leading cause of mortality worldwide.

This alarming trend is driven by several factors, including sedentary lifestyles, poor dietary choices, aging populations, and genetic predisposition. Chronic diseases, particularly diabetes and peripheral vascular diseases, often lead to chronic wounds. These wounds are slow to heal and prone to complications, such as infections and tissue necrosis. NPWT has emerged as an invaluable tool for managing these wounds effectively. NPWT promotes wound healing by creating a controlled environment that stimulates blood flow, reduces edema, and removes excess fluids. For patients with chronic wounds, NPWT can significantly accelerate the healing process and improve overall outcomes. Patients with chronic wounds are at higher risk of infections and other complications, which can lead to prolonged hospital stays and increased healthcare costs. NPWT can mitigate these risks, making it a cost-effective solution in the long run. Diabetic patients are particularly prone to foot ulcers, a common complication of diabetes. NPWT has demonstrated its effectiveness in managing diabetic foot ulcers, which are notorious for their slow healing and potential for amputation. As the number of individuals affected by chronic diseases continues to rise, so does the pool of potential NPWT patients. This expansion of the patient base is a significant driver of market growth.

Surgical Procedures

The Global Negative Pressure Wound Therapy (NPWT) market has been experiencing substantial growth, and one of the driving forces behind this expansion is the continuous evolution of surgical procedures. As surgical techniques become more advanced and widespread, the demand for innovative wound care solutions like NPWT is on the rise. Negative Pressure Wound Therapy, also known as vacuum-assisted closure (VAC) therapy, is a sophisticated medical approach used to expedite wound healing. It involves applying controlled negative pressure to a wound through a vacuum pump connected to a specialized dressing. This process removes excess fluids, stimulates blood flow, and encourages the growth of healthy tissue, leading to improved wound healing outcomes. Modern medicine has seen a surge in complex surgical procedures, including organ transplants, reconstructive surgeries, and bariatric surgeries. These operations often result in larger surgical wounds that require specialized wound care solutions like NPWT for optimal healing. Minimally invasive surgical techniques have gained popularity due to their reduced recovery times and minimal scarring. However, even these procedures may necessitate NPWT for optimal healing, especially in cases where larger incisions are made, or complications arise. Trauma and emergency surgeries are on the rise, driven by accidents and unforeseen medical events. NPWT can be a critical tool in managing wound care during emergency procedures, reducing the risk of complications.

Download Free Sample Report

Key Market Challenges

High Initial Costs

One of the primary challenges faced by the NPWT market is the relatively high initial costs associated with the technology. The equipment and consumables required for NPWT can be expensive for healthcare facilities, making it a significant investment. Smaller and underfunded healthcare institutions may find it challenging to afford these upfront costs.

Reimbursement Issues

NPWT reimbursement policies and practices can vary greatly between countries and regions. In some areas, healthcare providers struggle with inconsistent reimbursement rates or complicated billing processes. This can create uncertainty and hinder the adoption of NPWT.

Technological Barriers

While NPWT technology has advanced significantly, there is still room for improvement. Smaller, more portable devices are needed to improve patient mobility and comfort. Ensuring that NPWT systems are user-friendly and can be effectively used by healthcare professionals in various settings is an ongoing challenge.

Global Supply Chain Disruptions

The COVID-19 pandemic underscored the vulnerability of global supply chains. NPWT relies on the timely availability of consumables and equipment, and disruptions in the supply chain can impact patient care. Manufacturers and healthcare facilities need to ensure a robust supply chain to meet demand.

Key Market Trends

Portable and Wearable Devices

One of the most exciting developments in the NPWT market is the emergence of portable and wearable devices. Traditional NPWT systems are often bulky and require patients to remain immobile. However, wearable NPWT devices offer increased mobility and comfort, enabling patients to continue with their daily activities while receiving therapy. These compact, user-friendly devices are expected to revolutionize wound care and enhance patient compliance.

Connected Healthcare Ecosystem

The integration of NPWT systems into connected healthcare ecosystems is another significant trend on the horizon. These smart devices will enable healthcare providers to remotely monitor patients' progress, ensuring that the therapy is administered effectively. Real-time data collection and analysis will enhance decision-making, potentially reducing the risk of complications and improving patient outcomes.

Advanced Dressing Materials

Innovations in dressing materials are set to play a pivotal role in the NPWT market's future. Manufacturers are continuously researching and developing novel materials that can better conform to wound shapes, enhance fluid management, and improve patient comfort. These materials aim to make NPWT more effective and convenient for both patients and healthcare providers.

Bioactive NPWT Solutions

Bioactive NPWT solutions are designed to accelerate wound healing by promoting tissue regeneration and reducing inflammation. These next-generation therapies may incorporate growth factors, antimicrobial agents, and other bioactive substances to enhance the wound healing process. As research in this field progresses, bioactive NPWT may become a standard approach for complex wounds.

Segmental Insights

Product Insights

In 2024, the conventional devices category held the largest share of revenue, primarily attributed to their high cost and growing adoption. These systems necessitate hospital admission and are impractical for homecare use due to their reliance on heavy canisters. The availability of rental options for these devices is projected to boost NPWT utilization in developing nations where purchasing power is limited.

On the other hand, the single-use NPWT devices segment is anticipated to experience a lucrative Compound Annual Growth Rate (CAGR) in the coming years. This is because they find extensive applicability in home care settings, prompting major companies to emphasize enhancing their cost-efficiency. This strategic focus has proven to be an additional advantage for single-use NPWT devices, particularly in developing countries.

Wound Type Insights

Based on the category of Wound Type, the Pressure Ulcers segment emerged as the dominant player in the global market for negative pressure wound therapy in 2024 primarily due to the extended treatment duration required. Patients dealing with pressure ulcers typically need longer hospital stays, resulting in increased healthcare expenses. Another contributing factor to this growth is its emerging application for addressing pressure-related wounds like bedsores.

Conversely, the diabetic foot ulcers segment is expected to experience the most significant CAGR during the forecast period, mainly due to its remarkable success in NPWT treatment and the high prevalence of diabetes. Diabetic foot ulcers represent the most common form of chronic wounds, and NPWT plays a pivotal role in expediting the healing process for such injuries. Other wound categories include arterial ulcers and surgical wounds, among others.

Download Free Sample Report

Regional Insights

In 2024, North America claimed the most significant portion of revenue due to the increased healthcare spending and the highly advanced healthcare infrastructure within the region. Consequently, there has been a notable uptick in the adoption of NPWT devices, both in hospital settings and for homecare purposes. Meanwhile, in the Asia Pacific region, a promising CAGR is expected in the upcoming years. This projection primarily stems from the growing occurrence of traumatic incidents like burns, which subsequently fuels the demand for such therapy in this geographical area.

Recent Developments

In August 2023, Medela introduced the Invia Integrated Dressing, a sterile, peel-and-stick adhesive designed for various wound types, including closed surgical incisions. Compatible with Medela's Liberty and Motion NPWT pumps, it features a three-layer fluid handling pad with a skin-friendly silicone adhesive border and a Quick-connector for easy pump-to-dressing connection.
In May 2023, Smith+Nephew received an Innovative Technology contract from Vizient, Inc. for its PICO Single Use Negative Pressure Wound Therapy Systems. This award, based on recommendations from hospital experts, acknowledges PICO's potential to enhance healthcare by reducing surgical site infections and improving patient outcomes. The contract is expected to bolster Smith+Nephew's research and development efforts in negative pressure wound therapy, thereby driving market growth.
In April 2023, Convatec Group PLC acquired 30 Technology Limited's anti-infective nitric oxide technology platform, encompassing new product assets and research and development. This acquisition enhances Convatec's advanced wound care portfolio, with plans to launch a new product in 2025. Convatec intends to explore applications of this innovative technology across other business categories, including the prevention of urinary tract infections.
In January 2022, Smith & Nephew announced a new approved application for its PICO 7 and PICO 14 single-use negative pressure wound therapy devices by the United States Food and Drug Administration (FDA). The clearance from FDA allows these systems to be used on closed surgical incisions to assist in reducing the occurrence of wounds.
In October 2020, Pensar Medical introduced MicroDoc, the latest addition to their portfolio of negative pressure wound care systems. MicroDoc is designed for patients with shallow wounds that produce minimal exudate and no longer necessitate a full-sized system.

Key Market Players

Acelity LP Inc
Talley's Group Ltd
Smith & Nephew PLC
Devon Health Services Inc
Molnlycke Health Care AB
Medela AG
DeRoyal Industries Inc
ConvaTec Inc
Cardinal Health Inc
PAUL HARTMANN AG

By Product	By Wound Type	By End-use	By Region
Conventional NPWT Single-Use NPWT	Diabetic Foot Ulcers Venous Leg Ulcers Pressure Ulcers Burn Wounds Others	Hospitals Homecare Others	North America Europe Asia-Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Negative Pressure Wound Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Negative Pressure Wound Therapy Market, By Product:

o Conventional NPWT

o Single-Use NPWT

Negative Pressure Wound Therapy Market, By Wound Type:

o Diabetic Foot Ulcers

o Venous Leg Ulcers

o Pressure Ulcers

o Burn Wounds

o Others

Negative Pressure Wound Therapy Market, By End-use:

o Hospitals

o Homecare

o Others

Negative Pressure Wound Therapy Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ Germany

§ United Kingdom

§ France

§ Italy

§ Spain

o Asia-Pacific

§ China

§ Japan

§ India

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Negative Pressure Wound Therapy Market.

Available Customizations:

Global Negative Pressure Wound Therapy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Negative Pressure Wound Therapy Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Negative Pressure Wound Therapy Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product (Conventional NPWT, Single-Use NPWT)

5.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)

5.2.3. By End-use (Hospitals, Homecare, Others)

5.2.4. By Region

5.2.5. By Company (2024)

5.3. Product Market Map

5.3.1. By Product

5.3.2. By Wound Type

5.3.3. By End-use

5.3.4. By Region

6. North America Negative Pressure Wound Therapy Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product (Conventional NPWT, Single-Use NPWT)

6.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)

6.2.3. By End-use (Hospitals, Homecare, Others)

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Negative Pressure Wound Therapy Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product

6.3.1.2.2. By Wound Type

6.3.1.2.3. By End-use

6.3.2. Canada Negative Pressure Wound Therapy Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product

6.3.2.2.2. By Wound Type

6.3.2.2.3. By End-use

6.3.3. Mexico Negative Pressure Wound Therapy Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product

6.3.3.2.2. By Wound Type

6.3.3.2.3. By End-use

7. Europe Negative Pressure Wound Therapy Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product (Conventional NPWT, Single-Use NPWT)

7.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)

7.2.3. By End-use (Hospitals, Homecare, Others)

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Negative Pressure Wound Therapy Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product

7.3.1.2.2. By Wound Type

7.3.1.2.3. By End-use

7.3.2. United Kingdom Negative Pressure Wound Therapy Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product

7.3.2.2.2. By Wound Type

7.3.2.2.3. By End-use

7.3.3. France Negative Pressure Wound Therapy Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product

7.3.3.2.2. By Wound Type

7.3.3.2.3. By End-use

7.3.4. Italy Negative Pressure Wound Therapy Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product

7.3.4.2.2. By Wound Type

7.3.4.2.3. By End-use

7.3.5. Spain Negative Pressure Wound Therapy Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product

7.3.5.2.2. By Wound Type

7.3.5.2.3. By End-use

8. Asia-Pacific Negative Pressure Wound Therapy Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product (Conventional NPWT, Single-Use NPWT)

8.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)

8.2.3. By End-use (Hospitals, Homecare, Others)

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Negative Pressure Wound Therapy Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product

8.3.1.2.2. By Wound Type

8.3.1.2.3. By End-use

8.3.2. Japan Negative Pressure Wound Therapy Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product

8.3.2.2.2. By Wound Type

8.3.2.2.3. By End-use

8.3.3. India Negative Pressure Wound Therapy Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product

8.3.3.2.2. By Wound Type

8.3.3.2.3. By End-use

8.3.4. Australia Negative Pressure Wound Therapy Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product

8.3.4.2.2. By Wound Type

8.3.4.2.3. By End-use

8.3.5. South Korea Negative Pressure Wound Therapy Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product

8.3.5.2.2. By Wound Type

8.3.5.2.3. By End-use

9. South America Negative Pressure Wound Therapy Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product (Conventional NPWT, Single-Use NPWT)

9.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)

9.2.3. By End-use (Hospitals, Homecare, Others)

9.2.4. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Negative Pressure Wound Therapy Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product

9.3.1.2.2. By Wound Type

9.3.1.2.3. By End-use

9.3.2. Argentina Negative Pressure Wound Therapy Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product

9.3.2.2.2. By Wound Type

9.3.2.2.3. By End-use

9.3.3. Colombia Negative Pressure Wound Therapy Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product

9.3.3.2.2. By Wound Type

9.3.3.2.3. By End-use

10. Middle East and Africa Negative Pressure Wound Therapy Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product (Conventional NPWT, Single-Use NPWT)

10.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)

10.2.3. By End-use (Hospitals, Homecare, Others)

10.2.4. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Negative Pressure Wound Therapy Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product

10.3.1.2.2. By Wound Type

10.3.1.2.3. By End-use

10.3.2. Saudi Arabia Negative Pressure Wound Therapy Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product

10.3.2.2.2. By Wound Type

10.3.2.2.3. By End-use

10.3.3. UAE Negative Pressure Wound Therapy Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product

10.3.3.2.2. By Wound Type

10.3.3.2.3. By End-use

10.3.4. Kuwait Negative Pressure Wound Therapy Market Outlook

10.3.4.1. Market Size & Forecast

10.3.4.1.1. By Value

10.3.4.2. Market Share & Forecast

10.3.4.2.1. By Product

10.3.4.2.2. By Wound Type

10.3.4.2.3. By End-use

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Porter’s Five Forces Analysis

13.1. Competition in the Industry

13.2. Potential of New Entrants

13.3. Power of Suppliers

13.4. Power of Customers

13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Acelity LP Inc

14.1.1. Business Overview

14.1.2. Product Offerings

14.1.3. Recent Developments

14.1.4. Financials (As Reported)

14.1.5. Key Personnel

14.1.6. SWOT Analysis

14.2. Talley's Group Ltd

14.3. Smith & Nephew PLC

14.4. Devon Health Services Inc

14.5. Molnlycke Health Care AB

14.6. Medela AG

14.7. DeRoyal Industries Inc

14.8. ConvaTec Inc

14.9. Cardinal Health Inc

14.10. PAUL HARTMANN AG

15. Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Figure 1: Global Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 2: Global Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 3: Global Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 4: Global Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 5: Global Negative Pressure Wound Therapy Market Share, By Region, By Value, 2020-2030F

Figure 6: Global Negative Pressure Wound Therapy Market Map, By Product, Market Size (USD Million) & Growth Rate (%), 2024

Figure 7: Global Negative Pressure Wound Therapy Market Map, By Wound Type, Market Size (USD Million) & Growth Rate (%), 2024

Figure 8: Global Negative Pressure Wound Therapy Market Map, By End Use, Market Size (USD Million) & Growth Rate (%), 2024

Figure 9: Global Negative Pressure Wound Therapy Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2024

Figure 10: North America Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 11: North America Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 12: North America Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 13: North America Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 14: North America Negative Pressure Wound Therapy Market Share, By Country, By Value, 2020-2030F

Figure 15: United States Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 16: United States Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 17: United States Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 18: United States Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 19: Canada Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 20: Canada Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 21: Canada Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 22: Canada Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 23: Mexico Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 24: Mexico Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 25: Mexico Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 26: Mexico Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 27: Europe Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 28: Europe Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 29: Europe Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 30: Europe Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 31: Europe Negative Pressure Wound Therapy Market Share, By Country, By Value, 2020-2030F

Figure 32: Germany Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 33: Germany Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 34: Germany Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 35: Germany Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 36: United Kingdom Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 37: United Kingdom Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 38: United Kingdom Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 39: United Kingdom Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 40: France Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 41: France Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 42: France Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 43: France Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 44: Italy Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 45: Italy Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 46: Italy Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 47: Italy Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 48: Spain Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 49: Spain Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 50: Spain Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 51: Spain Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 52: Asia Pacific Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 53: Asia Pacific Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 54: Asia Pacific Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 55: Asia Pacific Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 56: Asia Pacific Negative Pressure Wound Therapy Market Share, By Country, By Value, 2020-2030F

Figure 57: China Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 58: China Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 59: China Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 60: China Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 61: India Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 62: India Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 63: India Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 64: India Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 65: Japan Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 66: Japan Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 67: Japan Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 68: Japan Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 69: South Korea Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 70: South Korea Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 71: South Korea Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 72: South Korea Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 73: Australia Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 74: Australia Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 75: Australia Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 76: Australia Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 77: South America Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 78: South America Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 79: South America Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 80: South America Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 81: South America Negative Pressure Wound Therapy Market Share, By Country, By Value, 2020-2030F

Figure 82: Brazil Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 83: Brazil Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 84: Brazil Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 85: Brazil Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 86: Argentina Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 87: Argentina Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 88: Argentina Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 89: Argentina Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 90: Colombia Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 91: Colombia Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 92: Colombia Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 93: Colombia Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 94: Middle East & Africa Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 95: Middle East & Africa Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 96: Middle East & Africa Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 97: Middle East & Africa Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 98: Middle East & Africa Negative Pressure Wound Therapy Market Share, By Country, By Value, 2020-2030F

Figure 99: South Africa Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 100: South Africa Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 101: South Africa Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 102: South Africa Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 103: Saudi Arabia Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 104: Saudi Arabia Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 105: Saudi Arabia Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 106: Saudi Arabia Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 107: UAE Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 108: UAE Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 109: UAE Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 110: UAE Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Figure 111: Kuwait Negative Pressure Wound Therapy Market Size, By Value (USD Million), 2020-2030F

Figure 112: Kuwait Negative Pressure Wound Therapy Market Share, By Product, By Value, 2020-2030F

Figure 113: Kuwait Negative Pressure Wound Therapy Market Share, By Wound Type, By Value, 2020-2030F

Figure 114: Kuwait Negative Pressure Wound Therapy Market Share, By End Use, By Value, 2020-2030F

Frequently asked questions

What was the market size of the Global Negative Pressure Wound Therapy Market in 2024?

The market size of the Global Negative Pressure Wound Therapy Market was estimated to be USD 2640.52 Million in 2024.

Who were the top players operating in the Global Negative Pressure Wound Therapy Market in 2024?

Acelity LP Inc, Talley's Group Ltd, Smith & Nephew PLC, Devon Health Services Inc, Molnlycke Health Care AB, Medela AG, DeRoyal Industries Inc, ConvaTec Inc, Cardinal Health Inc, PAUL HARTMANN AG were some of the key players operating in the Global Negative Pressure Wound Therapy Market.

What are the challenges faced by the Global Negative Pressure Wound Therapy Market in the upcoming years?

Reimbursement issues, technological barriers, global supply chain disruptions, are some of the major challenges faced by the Global Negative Pressure Wound Therapy Market in the upcoming years.

What are the major drivers for the Global Negative Pressure Wound Therapy Market?

Rise in chronic diseases and growth in surgical procedures are the major drivers for the Global Negative Pressure Wound Therapy Market.